The phase 3 trial data will clearly state the efficacy of the Covid-19 vaccine. Bharat Biotech, the developers of Covaxin, had already been in the dock for delay in announcing its trial data.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.